Nicholas Brousseau

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults and for adults at high risk of severe RSV disease.

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults and for adults at high risk of severe RSV disease.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: August 13, 2026

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance to protect infants and children from respiratory syncytial virus disease.

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance to protect infants and children from respiratory syncytial virus disease.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: August 13, 2026

Invasive Pneumococcal Disease Epidemiology and Conjugate Vaccines in Canada, 2000-2019.

Invasive Pneumococcal Disease Epidemiology and Conjugate Vaccines in Canada, 2000-2019.

Journal: JAMA network open

Published: April 09, 2026

2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.

2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, Canada.

Journal: Vaccine

Published: March 19, 2026

Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada.

Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada.

Journal: Human vaccines & immunotherapeutics

Published: January 13, 2026

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.

Journal: PloS one

Published: January 12, 2026

Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network.

Safety of COVID-19 vaccines among pregnant individuals in Quebec, Canada: a population-based retrospective cohort study from the Canadian Immunization Research Network.

Journal: BMJ open

Published: December 23, 2025

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada.

Nirsevimab effectiveness, number needed to immunize and impact on severe RSV outcomes, a test-negative study in Quebec, Canada.

Journal: Lancet regional health. Americas

Published: November 28, 2025

Impact of a multicomponent intervention on maternal Tdap vaccination coverage during a major pertussis resurgence in the province of Quebec, Canada: A quasi-experimental study.

Impact of a multicomponent intervention on maternal Tdap vaccination coverage during a major pertussis resurgence in the province of Quebec, Canada: A quasi-experimental study.

Journal: Human vaccines & immunotherapeutics

Published: November 17, 2025

Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study.

Does an off-label two-dose RotaTeq vaccine schedule translate into a higher incidence of rotavirus hospital admissions compared to the approved three-dose RotaTeq schedule? A Canadian immunization research network study.

Journal: Vaccine

Published: November 04, 2025

Serotype-specific pneumococcal conjugate vaccine effectiveness in Canadian children: an indirect cohort study using Bayesian hierarchical modeling of multisite data.

Serotype-specific pneumococcal conjugate vaccine effectiveness in Canadian children: an indirect cohort study using Bayesian hierarchical modeling of multisite data.

Journal: BMC infectious diseases

Published: October 21, 2025

Immunogenicity of Two Versus Three Doses of Hepatitis B Vaccine When Administered to Children Aged 2-18 Months: A Randomized Clinical Trial.

Immunogenicity of Two Versus Three Doses of Hepatitis B Vaccine When Administered to Children Aged 2-18 Months: A Randomized Clinical Trial.

Journal: The Journal of infectious diseases

Published: October 09, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026